Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Albrecht

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
BMC Public Health|March 28, 2026
Analysis of potential barriers for PrEP non-users among PrEP-eligible MSM in GermanyHelena Waldorf, Ulrich Marcus, Sara Iannuzzi, et al.
Polymers|January 11, 2024
Bringing Light into the Dark-Overview of Environmental Impacts of Carbon Fiber Production and Potential Levers for ReductionTobias Manuel Prenzel, Andrea Hohmann, Tim Prescher, et al.
Polymers|August 12, 2023
Sustainable Pultruded Sandwich Profiles with Mycelium CoreMarion Früchtl, Andreas Senz, Steffen Sydow, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2010
Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD studyAnthony H V Schapira, Stefan Albrecht, Paolo Barone, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2018
Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional studyFlorian Nolte, Holger Nückel, Burkhard Schmidt, et al.
Sleep Medicine|March 1, 2011
Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndromeBirgit Högl, Diego Garcia-Borreguero, Claudia Trenkwalder, et al.
The Lancet. Neurology|June 4, 2013
Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trialAnthony H V Schapira, Michael P McDermott, Paolo Barone, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 13, 2021
Janna Seifried, Alexandra Hoffmann, Sarah Reda, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2021
[Recording of SARS-CoV-2 laboratory tests in Germany]Janna Seifried, Alexandra Hoffmann, Sarah Reda, et al.
Scandinavian Journal of Work, Environment & Health|June 7, 2022
Occupation and SARS-CoV-2 infection risk among 108 960 workers during the first pandemic wave in GermanyMarvin Reuter, Mariann Rigó, Maren Formazin, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
BMC Public Health|March 28, 2026
Analysis of potential barriers for PrEP non-users among PrEP-eligible MSM in GermanyHelena Waldorf, Ulrich Marcus, Sara Iannuzzi, et al.
Polymers|January 11, 2024
Bringing Light into the Dark-Overview of Environmental Impacts of Carbon Fiber Production and Potential Levers for ReductionTobias Manuel Prenzel, Andrea Hohmann, Tim Prescher, et al.
Polymers|August 12, 2023
Sustainable Pultruded Sandwich Profiles with Mycelium CoreMarion Früchtl, Andreas Senz, Steffen Sydow, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2010
Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD studyAnthony H V Schapira, Stefan Albrecht, Paolo Barone, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2018
Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional studyFlorian Nolte, Holger Nückel, Burkhard Schmidt, et al.
Sleep Medicine|March 1, 2011
Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndromeBirgit Högl, Diego Garcia-Borreguero, Claudia Trenkwalder, et al.
The Lancet. Neurology|June 4, 2013
Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trialAnthony H V Schapira, Michael P McDermott, Paolo Barone, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 13, 2021
Janna Seifried, Alexandra Hoffmann, Sarah Reda, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2021
[Recording of SARS-CoV-2 laboratory tests in Germany]Janna Seifried, Alexandra Hoffmann, Sarah Reda, et al.
Scandinavian Journal of Work, Environment & Health|June 7, 2022
Occupation and SARS-CoV-2 infection risk among 108 960 workers during the first pandemic wave in GermanyMarvin Reuter, Mariann Rigó, Maren Formazin, et al.
Pageof 4